GRIP Molecular Technologies

GRIP Molecular Technologies Inc.

41 Investors
Molecular Diagnostics
SAINT PAUL, MN

GRIP Molecular Technologies Inc. is a Minnesota-based company specializing in molecular diagnostics by providing laboratory-quality diagnostic results directly at various points of need. Their focus is on overcoming the limitations of traditional diagnostic technologies, particularly in terms of speed, performance, and cost, to facilitate effective point-of-care applications.

Products & Team

Single-Use Biosensor Diagnostic Test System

Diagnostic TestingSeed

This diagnostic test system incorporates a solid-state biosensor that utilizes advanced chemical vapor deposition graphene technology, replacing traditional chemical assays. It enables the detection of multiple diseases with fast, wireless result transmission to mobile devices.

Value Proposition

The technology provides quick, accurate diagnostics without needing centralized labs, addressing the urgent health needs for timely disease identification.

Pain Points

The need for timely, reliable diagnostics without the inconvenience of traveling to centralized laboratories, particularly in urgent or remote care situations.

Single-use biosensorGraphene-enabled technologyDielectrophoresis-enhanced electronicsWireless result transmission to smartphonesMulti-disease detection in one test
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
SAINT PAUL, MN
Primary headquarters

Funding History

Total Raised:
$8.8M
E

Debt Financing, Option to Acquire Offering

December 2019
$12.0M
Target
Progress
73%
Raised
$8.8M
Target
$12.0M
#000179760025000008